THE ACTIVITY OF CILOFUNGIN ON THE INCORPORATION OF GLUCAN ASSOCIATED PROTEINS INTO HYPHAL CELLS OF CANDIDA-ALBICANS

被引:1
作者
ANGIOLELLA, L [1 ]
FACCHIN, M [1 ]
SIMONETTI, N [1 ]
CASSONE, A [1 ]
机构
[1] UNIV ROMA LA SAPIENZA,FAC FARM,IST MICROBIOL,ROME,ITALY
关键词
CILOFUNGIN; CANDIDA ALBICANS; GLUCAN SYNTHASE INHIBITOR; FUNGI;
D O I
10.1179/joc.1995.7.2.83
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effect of the cilofungin, a beta 1-3 glucan synthase inhibitor, on the incorporation of the glucan associated proteins (GAP) into the mycelial wall of Candida albicans was investigated. For this study sub-inhibitory (< 2 mu g/ml) doses of cilofungin were employed during the yeast to mycelial transition in a defined chemical medium, at 37 degrees C for 24 hours. Under these conditions, and particularly at the dose of 0.50 mu g/ml cilofungin exerted a marked effect on GAP incorporation into the mycelial cell wall. The changes were essentially the absence of the two prominent bands of 46 and 31 kDa of the untreated cell wall coupled with an apparent increase in the amount of 55-56 kDa constituent, as well as of a minor constituent of 27-28 kDa. Radiolabel incorporation experiments demonstrated increased synthesis of a 34 kDa GAP, in addition to confirming the absence of the 46 kDa constituent, in mycelial cells under cilofunging treatment. Thus, sub-inhibitory doses of cilofungin may greatly alter the pattern of essential cell wall constituents such as the glucan-associated proteins, suggesting that this drug also has important effects on eel wall structure and fine organization, independent of, or prior to, its principal lytic effect on the fungal organism.
引用
收藏
页码:83 / 89
页数:7
相关论文
共 19 条
[1]  
Gordee R.S., Zeckner D.J., Ellis L.F., Thakkar A.L., Howard L.C., In vitro and in vivo anti- Candida activity and toxicology of LY 121019, J Antibiot, 37, pp. 1054-1065, (1984)
[2]  
Hall G.S., Gyles C., Pratt K.J., Washington J.A., Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis, Antimicrob Agents Chemother, 32, pp. 1331-1335, (1988)
[3]  
Taft C.S., Stark T., Selitrennikoff C.P., Cilofungin (LY121019) inhibits Candida albicans (1-3)-P-D-glucan synthase activity, Antimicrob Agents Chemother, 32, pp. 1901-1903, (1988)
[4]  
Sawistowska-Schroder E.T., Kerridge D., Perry H., Echinocandin inhibition of 1.3-pD-glucan synthase from Candida albicans, FEBS Letters, 173, pp. 134-138, (1981)
[5]  
Shepherd M.G., Cell envelope of Candida albicans, CRC Crit Rev Microbiol, 15, pp. 7-16, (1987)
[6]  
Surarit R., Gopal P.K., Shepherd M.G., Evidence for a gly- cosidic linkage between chitin and glucan in the cell wall of Candida albicans, J Gen Microbiol, 134, pp. 1723-1730, (1988)
[7]  
Cassone A., Cell wall of pathogenic yeasts and implications for antimycotic therapy, Drugs Exptl Clin Res, 12, pp. 635-643, (1986)
[8]  
Torosantucci A., Boccanera M., Casalinuovo I., Pellegrini G., Cassone A., Differences in the antigenic expression of immunomodulatory mannoprotein constituents on yeast and mycelial forms of Candida albicans, J Gen Microbiol, 136, pp. 1421-1428, (1990)
[9]  
Gil M.L., Casanova M., Martinez J.P., Sentandreu R., Antigenic cell wall mannoproteins in Candida albicans isolates and in other Candida species, J Gen Microbiol, 137, pp. 1053-1061, (1991)
[10]  
Cassone A., Cell wall of Candida albicans: Its functions and its impact on the host, Curr Top Med Mycol, 3, pp. 249-314, (1989)